Table 4.
N | 19 + 21 | p-value | N | 23 | p-value | N | > 23 | p-value | ||
---|---|---|---|---|---|---|---|---|---|---|
Peak gradient mmHg (sd) | ||||||||||
Magna | IPT | 43 | 24.0 (11.4) | 0.02 | 117 | 21.3 (8.8) | 0.001 | 165 | 18.3 (7.5) | 0.01 |
CST | 36 | 18.3 (10.0) | 142 | 18.4 (5.9) | 364 | 16.1 (6.4) | ||||
Trifecta | IPT | 37 | 17.7 (6.7) | 0.003 | 98 | 16.2 (7.3) | 0.001 | 65 | 13.8 (7.1) | 0.45 |
CST | 38 | 13.7 (6.5) | 89 | 12.4 (5.0) | 107 | 13.1 (5.5) | ||||
Mean gradient mmHg (sd) | ||||||||||
Magna | IPT | 43 | 13.2 (6.5) | 0.01 | 117 | 11.5 (5.0) | 0.001 | 165 | 10.0 (4.3) | 0.001 |
CST | 36 | 9.8 (4.8) | 142 | 9.6 (3.2) | 364 | 8.6 (3.7) | ||||
Trifecta | IPT | 37 | 9.3 (3.6) | 0.003 | 98 | 8.2 (4.0) | 0.001 | 65 | 7.0 (4.3) | 0.67 |
CST | 38 | 7.1 (3.6) | 89 | 6.4 (2.9) | 107 | 6.8 (3.1) |
CST: Continues suture technique; IPT: Interrupted pledgeted technique, N: Number of patients available for analysis; The numbers (19, 21, 23) indicate the size of prosthesis as indicated by the companies